Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Last thing they said on TFC-039

<< Previous

Bullboard Posts

Next >>

Comment by str8goods4achgon Dec 13, 2021 12:05pm

172 Views

Post# 34225307

RE:Last thing they said on TFC-039

Given the current gov and business climate, I for one am happy to have them move on from anything in China. It has been a distraction and there was a growing likelihood that they wouldn't be able to execute the business plan as China becomes more and more protectionalist.

My hope is that they don't explore anymore opportunities in China until there is a more favorable business climate and stability returns to the region... if it ever does.

GLTA

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta